Skip to main content
Clinical Trials/NCT03719209
NCT03719209
Unknown
N/A

Using Virtual Reality to Foster Engagement, Understanding, and Knowledge in Patients With Gastrointestinal Disease and Their Families

Boston Children's Hospital1 site in 1 country200 target enrollmentSeptember 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Gastrointestinal Disease
Sponsor
Boston Children's Hospital
Enrollment
200
Locations
1
Primary Endpoint
Patient and family knowledge, understanding, and satisfaction
Last Updated
6 years ago

Overview

Brief Summary

The primary aim of this study is to evaluate the effect and impact of a technology which creates a virtual reality (VR), personalized representation of a patient's endoscopic findings in comparison our standard practice (SP). Our study will compare the level of knowledge, understanding and satisfaction the patient and family have between those receiving SP and those receiving both SP and VR.

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
October 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Docktor

Attending Physician, Division of Gastroenterology, Hepatology, and Nutrition

Boston Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients aged 8-25 years of age who are willing and able to participate
  • Patients who recently had an endoscopic procedure at Boston Children's Hospital

Exclusion Criteria

  • Patients who are unable to provide consent due to age or developmental status

Outcomes

Primary Outcomes

Patient and family knowledge, understanding, and satisfaction

Time Frame: 1 month

Our study will measure the levels of patient and family engagement using a survey designed specifically for the study. The survey is at a roughly 3rd grade reading level and includes approximately 10 questions with answers on a Likert scale. The internally designed survey will specifically measure patient and family opinions on learning about the results of their procedure, as well as objective anatomical knowledge. The minimum score for each question is a 1, designating "Strongly disagree." The maximum score for each question is a 10, designating "Strongly agree." Thus, higher scores represent better outcomes.

Secondary Outcomes

  • Patient Satisfaction Scale(1 month)
  • Longitudinal Readmission Rate(up to 5 years)
  • Longitudinal Medication Adherence(up to 5 years)
  • Client Satisfaction Questionnaire(1 month)

Study Sites (1)

Loading locations...

Similar Trials